Retatrutide
Triple receptor (GIP / GLP-1 / glucagon) agonist research peptide for metabolic studies.
Retatrutide is a triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors. It represents an advanced area of metabolic research and is offered as a high-purity lyophilized research peptide.
Ingredients
Retatrutide (≥98% purity by HPLC). 10 mg lyophilized peptide per vial. No non-active ingredients.
Directions
For research use only. Reconstitute per study protocol. Store lyophilized at 2–8°C, protected from light.
Warnings
NOT FOR HUMAN OR ANIMAL CONSUMPTION. Research use only. Not approved for human use. Not intended to diagnose, treat, cure, or prevent any disease.
Shipping Information
- • Dispatched within 24 hours on business days
- • Discreet, temperature-aware packaging
- • Tracking provided on every shipment
- • Free shipping on orders over $150
Specifications
Customer Reviews
Excellent purity and consistent third-party results across multiple batches.
Satisfied with the product and documentation provided.
Purity confirmed by independent HPLC. Would order again.
Good value for the research being conducted. Fast shipping.
We have ordered several times and the quality has been consistent every time.
Related Products
Semaglutide
GLP-1 receptor agonist research peptide studied for appetite regulation and metabolic health.
Tirzepatide
Dual GIP / GLP-1 receptor agonist research peptide studied for metabolic physiology.
Tesamorelin
Stabilised GHRH analog studied for visceral adipose tissue and metabolic research.